- Screening
- Baseline
- In the process of the treatment
- At the end of the treatment
- Follow-up 1
- Follow-up 2
- Follow-up 3
- Management system of participants
- Speciman management system
- Data management system
- ADR/ADE management system
- Madicine management system
- Instruments management system
- SOPs
- Research team
- Design, Methods
|
Eligible participant has to fullfill all of the following items | / / / / / / |
|
|
|
Date | yyyy-mm-dd |
- General information
- Physical examination
- Blood Routine Tests
- Urine and Stool Routine Tests
- Glucose test
- Serum Liver Function Tests
- Renel Function Test
- Heat Function Examination
- Image Examinations
|
Gender | Male
|
|
Your age | 72 岁(years) |
|
Date of birth: | 1957-03-17 yyyy-mm-dd |
|
Nationality | Han
|
|
Marriage history | |
|
Pulse rate | 次/分 |
|
Breath frequency | 次/分 |
|
Systolic pressure (SP) | mmHg |
|
Diastolic pressure | mmHg |
|
Did you experienced any drug allergy? | |
|
Namy of the drug to be allergied |
|
|
Date of drug allergy happened | yyyy-mm-dd/mm-dd |
|
Doctor signature |
|
|
Date | yyyy-mm-dd |
间断多尿、多饮8年，右足溃烂25天，加重1天。患者8年前诊断为2型糖尿病，口服二甲双胍片0.5日三次，格列苯脲2.5毫克日三次，血糖好转，3年前口服药失效，改为重组人胰岛素20单位，20单位早晚餐前15分钟皮下注射，血糖控制可，25天前右足溃烂。 |
|
|
Wagner grade | |
|
Signature of the doctor |
|
|
Date of examination | yyyy-mm-dd |
|
WBC | 19.8 ×109 /L |
|
NEUT% | 84 % |
|
LY% | 7.3 % |
|
MONO％ | 6.8 ％ |
|
RBC | 3.76 ×10^12 /L |
|
HGB | 118 g/L |
|
PLT | 361 ×10^9 /L |
|
Date | yyyy-mm-dd |
|
Acidity and allkalinity | Acidity
|
|
pH value | ＜5 |
|
Urine protein | Positive+++
|
|
Urine red cell | Suspending
|
|
Urine WBC | Suspending
|
|
Urine glucos | Positive++
|
|
Urine Bilirubin | Negative
|
|
Urine HCG | Negative
|
|
KET | Negative
|
|
SG | ＞1 |
|
UBG | Negative
|
|
NIT | Negative
|
|
Date of test | yyyy-mm-dd |
|
Fasting blood glucos concentration | 7.5 mmol/L |
|
Two hours after breakfast | mmol/L |
|
Two hours after lunch | mmol/L |
|
Two hours after dinner | mmol/L |
|
Date of test | yyyy-mm-dd |
|
CRP | mg/L |
|
Date of test | yyyy-mm-dd |
|
Fib | g/L |
|
t-PA | ug/L |
|
PAI-1 | ug/L |
|
Date of test |
|
|
HbA1c | % |
|
Date of test | yyyy-mm-dd |
|
|
|
Signature of the doctor |
|
|
Date of examination | yyyy-mm-dd |
/uploads/patrecord/5541/param337295/870db167-c22a-4585-a224-9804f2cba9b8.jpg |
|
|
|
ALT | 26 IU/L |
|
AST | 29 IU/L |
|
γ-Glutamyltransferase | 64 IU/L |
|
Serum bilirubin | 11.9 μmol/L |
|
Indirect bilirubin | 6.1 umol/L |
|
Direct bilirubin | 5.8 umol/L |
|
Serum albumin | 26 g/L |
|
Serum total protein | 69 g/L |
|
Date of test | yyyy-mm-dd |
|
Blood uric acid | μmol/L |
|
SCr | μmol/L |
|
Blood urea | mmol/L |
|
Date of test | yyyy-mm-dd |
|
Ultrasonic echocardiography, UCG | |
|
Description in detail for abnormal |
|
|
Date of examination | yyyy-mm-dd |
|
AST | U |
|
LDH | IU |
|
Lactic dehydrogenase isoenzyme | |
|
α-HBDH | U/L |
|
Creatine Kinase, CK | U/L |
|
Creatine kinase isoenzyme, CKMB | U/L |
|
Date of tests | yyyy-mm-dd |
/uploads/patrecord/5541/param337311/bdbf710a-ef0a-466a-8cbf-3e87da1b27c8.jpg |
|
|
|
|
|
Signature of the doctor |
|
|
Date of examination | yyyy-mm-dd |
|
|
|
Signature of the doctor |
|
yyyy-mm-dd |
|
|
|
ALT | IU/L |
|
AST | IU/L |
|
AST/ALT |
|
|
γ-Glutamyltransferase | IU/L |
|
GGT | U/L |
|
Serum bilirubin | μmol/L |
|
Indirect bilirubin | umol/L |
|
Direct bilirubin | umol/L |
|
Serum albumin | g/L |
|
Serum globulin | g/L |
|
Serum total protein | g/L |
|
A/G |
|
|
Date of test | yyyy-mm-dd |
|
BUN | 8mmol/L |
|
SCr | μmol/L |
|
Blood urea | mmol/L |
|
Blood uric acid | μmol/L |
|
Cr |
|
|
Blood endogenous creatinine clearance | ml·s-1/m*2 |
|
BUN/Cr |
|
|
Date of test | yyyy-mm-dd |
|
|
|
|
|
|
|
|
ALT | IU/L |
|
AST | IU/L |
|
AST/ALT |
|
|
γ-Glutamyltransferase | IU/L |
|
Serum bilirubin | μmol/L |
|
Indirect bilirubin | umol/L |
|
Direct bilirubin | umol/L |
|
Serum albumin | g/L |
|
Serum globulin | g/L |
|
Serum total protein | g/L |
|
A/G |
|
|
Date of test | yyyy-mm-dd |
|
BUN | 8mmol/L |
|
SCr | μmol/L |
|
Blood urea | mmol/L |
|
Blood uric acid | μmol/L |
|
Cr |
|
|
Date of test | yyyy-mm-dd |
- Management for Progress
- Blood Routine Tests
- Glucose test
- Liver Function Tests
- Renel Function Test
- Heat Function Examination
- Image Examinations
- Health Relative Quality of Life
|
Is there any additional combination drug? | |
次 |
|
WBC | ×109 /L |
|
NEUT% | % |
|
LY% | % |
|
MONO％ | ％ |
|
RBC | ×10^12 /L |
|
HGB | g/L |
|
PLT | ×10^9 /L |
|
Researcher signature |
|
|
Date | yyyy-mm-dd |
|
HbA1c | % |
|
Date of test | yyyy-mm-dd |
|
Blood glucose | mmol/L |
|
LAGE |
|
|
MAGE |
|
|
SDBG |
|
|
MODD |
|
|
LBGI |
|
|
Date of test | yyyy-mm-dd |
|
Daily usage of insulin | IU |
|
Date of detection | yyyy-mm-dd |
|
ALT | IU/L |
|
AST | IU/L |
|
AST/ALT |
|
|
γ-Glutamyltransferase | IU/L |
|
Serum bilirubin | μmol/L |
|
Indirect bilirubin | umol/L |
|
Direct bilirubin | umol/L |
|
Serum albumin | g/L |
|
Serum globulin | g/L |
|
Serum total protein | g/L |
|
A/G |
|
|
Date of test | yyyy-mm-dd |
|
BUN | 8mmol/L |
|
SCr | μmol/L |
|
Blood urea | mmol/L |
|
Blood uric acid | μmol/L |
|
Cr |
|
|
Date of test | yyyy-mm-dd |
|
Ultrasonic echocardiography, UCG | |
|
Description in detail for abnormal |
|
|
Date of examination | yyyy-mm-dd |
|
AST | U |
|
LDH | IU |
|
Lactic dehydrogenase isoenzyme | |
|
α-HBDH | U/L |
|
Creatine Kinase, CK | U/L |
|
Creatine kinase isoenzyme, CKMB | U/L |
|
Date of tests | yyyy-mm-dd |
|
Before primary wounding | 分 |
|
Now (Current at moment) | 分 |
|
|
|
Signature of the doctor |
|
|
Date of examination | yyyy-mm-dd |
|
Whether got the informed consent? | |
|
Date of sign the informed consent | xx年xx月xx日 |
|
Adverse events | |
|
Name of the adverse event |
|
|
Date of starting | yyyy-mm-dd |
|
Ending time | yyyy-mm-dd |
|
Does it continues to now | |
|
Severity | |
|
Corelation with the study drug | |
|
The method of treating the drug | |
|
The outcome | |
|
Is it sevious adverse event? | |
|
Did it resulted in stoped the study? | |
|
Possible reason of causing the adverse event | |
|
Person who report the adverse event |
|
|
Time of the reporting | yyyy-mm-dd-hh-min. |